Protective effect of Enicostemma axillare - Swertiamarin on oxidative stress against nicotine-induced liver damage in SD rats
View abstract on PubMed
Summary
This summary is machine-generated.Swertiamarin (ST) protects against nicotine-induced liver damage in rats. This study shows ST administration prevents nicotine
Area Of Science
- Pharmacology and Toxicology
- Hepatoprotective Agents
- Oxidative Stress Research
Background
- Nicotine exposure is a significant risk factor for liver damage.
- Hepatotoxicity induced by nicotine can lead to severe liver dysfunction.
- Exploring natural compounds for protective effects against toxin-induced liver injury is crucial.
Purpose Of The Study
- To evaluate the hepatoprotective effects of Swertiamarin (ST) against nicotine-induced liver injury in Sprague-Dawley (SD) rats.
- To investigate the impact of ST on liver function enzymes and oxidative stress markers following nicotine exposure.
- To assess the histological changes in liver tissue after nicotine administration and ST co-treatment.
Main Methods
- Adult male SD rats were divided into six groups, receiving nicotine (IP), Swertiamarin (PO), or a combination for 65 days.
- Liver tissues were analyzed for histopathological changes and biochemical markers, including liver function enzymes and oxidative stress parameters.
- Key oxidative stress markers assessed included Malondialdehyde (MDA), Catalase (CAT), Glutathione (GSH), and Superoxide dismutase (SOD).
Main Results
- Nicotine administration significantly elevated liver enzymes (AST, ALT), urea, and creatinine levels.
- Nicotine-induced liver injury was characterized by increased MDA and decreased levels of CAT, GSH, and SOD, indicating significant oxidative stress.
- Co-administration of Swertiamarin with nicotine attenuated nicotine-induced hepatotoxicity and reversed histological damage.
Conclusions
- Swertiamarin demonstrates significant hepatoprotective potential against nicotine-induced liver damage in rats.
- ST effectively mitigates oxidative stress and preserves liver architecture compromised by nicotine exposure.
- Further research is warranted to elucidate the precise mechanisms underlying Swertiamarin's protective effects against nicotine hepatotoxicity.

